%0 Journal Article %1 sexton_new_2004 %A Sexton, Kerry %A Lennon, Diana %A Oster, Philipp %A Crengle, Sue %A Martin, Diana %A Mulholland, Kim %A Percival, Teuila %A Reid, Stewart %A Stewart, Joanna %A O'Hallahan, Jane %D 2004 %J The New Zealand Medical Journal %K B, Disease Factors Humans, Immunization Infections, Meningococcal Neisseria New Outbreaks, Population Postmarketing, Product Programs, Risk Serogroup Surveillance, Vaccines, Zealand, meningitidis, %N 1200 %P U1015 %R 15475985 %T The New Zealand Meningococcal Vaccine Strategy: a tailor-made vaccine to combat a devastating epidemic %U http://www.ncbi.nlm.nih.gov/pubmed/15475985 %V 117 %X The New Zealand Meningococcal Vaccine Strategy aims to end the devastating 14-year epidemic of B:4:P1.7b,4 group B meningococcal disease in New Zealand through a mass immunisation programme to all under 20 year olds using a tailor-made vaccine (MeNZB). This paper describes the scientific rationale, development, and key components of the New Zealand Meningococcal Vaccine Strategy. A summary of the efficacy and safety data of existing outer membrane vesicle group B meningococcal vaccines is included as these data critically support the Strategy.

@article{sexton_new_2004, abstract = {The New Zealand Meningococcal Vaccine Strategy aims to end the devastating 14-year epidemic of {B:4:P1.7b,4} group B meningococcal disease in New Zealand through a mass immunisation programme to all under 20 year olds using a tailor-made vaccine {(MeNZB).} This paper describes the scientific rationale, development, and key components of the New Zealand Meningococcal Vaccine Strategy. A summary of the efficacy and safety data of existing outer membrane vesicle group B meningococcal vaccines is included as these data critically support the Strategy.}, added-at = {2011-03-11T10:05:34.000+0100}, author = {Sexton, Kerry and Lennon, Diana and Oster, Philipp and Crengle, Sue and Martin, Diana and Mulholland, Kim and Percival, Teuila and Reid, Stewart and Stewart, Joanna and {O'Hallahan}, Jane}, biburl = {https://www.bibsonomy.org/bibtex/2bd241e17516d5bd994e8cd76e01e2ee6/jelias}, doi = {15475985}, interhash = {ef7fa6df45428151e5c286169bec67e5}, intrahash = {bd241e17516d5bd994e8cd76e01e2ee6}, issn = {1175-8716}, journal = {The New Zealand Medical Journal}, keywords = {B, Disease Factors Humans, Immunization Infections, Meningococcal Neisseria New Outbreaks, Population Postmarketing, Product Programs, Risk Serogroup Surveillance, Vaccines, Zealand, meningitidis,}, month = aug, note = {{PMID:} 15475985}, number = 1200, pages = {U1015}, shorttitle = {The New Zealand Meningococcal Vaccine Strategy}, timestamp = {2011-03-11T10:06:47.000+0100}, title = {The New Zealand Meningococcal Vaccine Strategy: a tailor-made vaccine to combat a devastating epidemic}, url = {http://www.ncbi.nlm.nih.gov/pubmed/15475985}, volume = 117, year = 2004 }